drugset / Trial / NCT00002793

Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer

NCT00002793 ↗

Phase 3 Unknown 336 enrolled Johann Wolfgang Goethe University Hospital
RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug or giving the drugs in different ways may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy administered via an implantable pump with a subcutaneous port for unresectable liver metastases in patients with resected primary colorectal cancer.

Timeline

Start
1991-01
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Leucovorin Small molecule — Other
Subject fluorouracil Small molecule — Other